易方达标普生物科技人民币C(012866)

动态评分: 6.09分

投资组合

报告日期 名称 比例
2024-12-31 Allogene Therapeutics Inc 0.13%
2024-12-31 Anavex Life Sciences Corp 0.13%
2024-12-31 Verve Therapeutics Inc 0.13%
2024-12-31 REGENXBIO Inc 0.12%
2024-12-31 Keros Therapeutics Inc 0.12%
2024-12-31 ArriVent BioPharma Inc 0.12%
2024-12-31 89bio Inc 0.12%
2024-12-31 Stoke Therapeutics Inc 0.12%
2024-12-31 Dianthus Therapeutics Inc 0.1%
2024-12-31 Tourmaline Bio Inc 0.1%
2024-12-31 LENZ Therapeutics Inc 0.09%
2024-12-31 Sana Biotechnology Inc 0.09%
2024-12-31 Erasca Inc 0.09%
2024-12-31 KalVista Pharmaceuticals Inc 0.08%
2024-12-31 MiMedx Group Inc 0.08%
2024-12-31 Savara Inc 0.08%
2024-12-31 Cargo Therapeutics Inc 0.08%
2024-12-31 Olema Pharmaceuticals Inc 0.08%
2024-12-31 Arbutus Biopharma Corp 0.08%
2024-12-31 Celcuity LLC 0.07%

投资模拟

公告&资料